IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer

Description

The purpose of this research is to assess how patients with cancer being treated with Immune Checkpoint Inhibitors (ICI) manage symptoms related to cancer and/or its treatment. Patients use a variety of ways to manage symptoms including traditional and alternative treatments including cannabis, acupuncture, etc. This research will have an important impact on our knowledge of cancer symptom management, and ultimately improve patient care and safety. Participants will complete online surveys and 7 days of ecological momentary assessments at 0, 1, 2, 4, 6, 9 and 12 month to compare the cannabis users and non cannabis users symptoms.

Conditions

Cancer

Study Overview

Study Details

Study overview

The purpose of this research is to assess how patients with cancer being treated with Immune Checkpoint Inhibitors (ICI) manage symptoms related to cancer and/or its treatment. Patients use a variety of ways to manage symptoms including traditional and alternative treatments including cannabis, acupuncture, etc. This research will have an important impact on our knowledge of cancer symptom management, and ultimately improve patient care and safety. Participants will complete online surveys and 7 days of ecological momentary assessments at 0, 1, 2, 4, 6, 9 and 12 month to compare the cannabis users and non cannabis users symptoms.

Assessing Benefits and Harms of Cannabis Use in Patients Treated with Immunotherapy for Cancer: a Prospective Cohort Study

IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

Portland

Oregon Health and Science University, Portland, Oregon, United States, 97239

Philadelphia

Thomas Jefferson University, Philadelphia, Pennsylvania, United States, 19107

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * adult age of 21 years or older
  • * cancer diagnosis and planning or using immunotherapy treatment,
  • * pain and spend less than 50% in bed or chair
  • * fluent in english language
  • * use synthetic cannabis or only use Cannabidiol (CBD)
  • * non users but used in the past 3 months
  • * prior immunotherapy, Patients receiving immunosuppressants or organ transplant recipients.
  • * Patients within 6 months of Hospice care.
  • * Pain that limits movement to more than 50% of their day in bed or chair

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

State University of New York at Buffalo,

Study Record Dates

2027-12-31